GLP-1 third doses after bariatric surgery: what the data says

What did @itsjohannanavarro actually say?

She noticed nausea the morning after missing her third tirzepatide dose and wondered aloud whether the drug "wearing off" could be causing her symptoms. Her words: "I think now that it's wearing off I am" feeling nauseous. She also briefly floated pregnancy as a possibility before dismissing it. Then she announced she'd take her missed dose about 13 hours late, first thing Wednesday morning.

This is a reasonable, genuine question from someone paying attention to her own body. She's not making wild claims, she's pattern-matching based on timing. That part is actually worth taking seriously. What she gets wrong is the pharmacology behind why it might be happening, and the decision to just take it the next morning without flagging it to a prescriber.

Does the science back this up?

Sort of, but not in the way she's framing it. Nausea from tirzepatide discontinuation or dose delays isn't well-documented as a formal withdrawal phenomenon, but there's a plausible mechanism worth understanding.

Tirzepatide works on both GIP and GLP-1 receptors, and GLP-1 receptor agonists are known to affect gastric emptying and gut motility significantly. A 2022 study by Frías et al. in The New England Journal of Medicine confirmed that tirzepatide slows gastric emptying in a dose-dependent way. When that slowing effect drops off, even temporarily, the gut may respond to a kind of motility rebound. This isn't the same as classic withdrawal, but it could explain why some people feel off when a dose is delayed.

There's also a simpler explanation: she may have just eaten something that didn't agree with her, or her baseline nausea sensitivity is reasserting itself now that the drug's appetite-suppressing, motility-altering effects are partially fading. Tirzepatide has a half-life of approximately five days, so 13 hours late is unlikely to cause a dramatic drop in drug levels. The more probable explanation is individual sensitivity, not pharmacological withdrawal.

What did they get wrong (or right)?

She got the instinct right: drug timing can affect how your body feels, and it's smart to connect symptoms to your medication schedule. That's good self-monitoring.

What she got wrong is the framing of "wearing off" as a rapid process. Tirzepatide's roughly five-day half-life means her drug levels at 13 hours post-missed-dose were not dramatically lower than usual. If she's feeling nauseous, it's more likely her body's baseline GI sensitivity reasserting itself, or a completely unrelated cause, than a pharmacokinetic cliff.

The other concern is her self-directed decision to just take the dose Wednesday morning with no mention of checking in with her prescriber. The FDA prescribing information for tirzepatide (Mounjaro/Zepbound) states that if a dose is missed, it can be administered within four days of the scheduled day. She was within that window, so the decision itself isn't dangerous, but defaulting to provider guidance rather than self-managing in a comments section is always the better move.

She also dismissed pregnancy a little too quickly given she's a reproductive-age woman on a medication not approved for use during pregnancy. That's worth a real conversation with a clinician, not a TikTok footnote.

What should you actually know?

Missing a single tirzepatide dose by 13 hours is unlikely to produce dramatic pharmacological withdrawal because the drug's half-life is long enough to buffer short delays. However, nausea can be unpredictable with GLP-1 and GIP receptor agonists, especially during the early titration phase when the body is still adjusting.

The FDA's official guidance on missed tirzepatide doses is clear: if you miss a dose and it's within four days of your scheduled injection day, take it as soon as you remember. If more than four days have passed, skip it and resume your regular schedule. Do not take two doses to make up for a missed one.

Persistent or unexpected nausea, especially nausea that's new and doesn't fit your usual pattern on the medication, is worth reporting to your prescriber. It could be the drug, it could be something else entirely, and only a provider who knows your full history can help you sort that out. Self-diagnosing in a TikTok video, even a thoughtful one, is not a substitute for that conversation.

• Tirzepatide is not approved for use during pregnancy. Anyone on tirzepatide who is or may be pregnant should contact their prescriber immediately.
• GI symptoms during dose transitions are common and not always a sign something is wrong, but they should be monitored.
• The comments section of a WLS TikTok video is not a clinical consultation.